These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30943199)

  • 1. Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016.
    George CRR; Enriquez RP; Gatus BJ; Whiley DM; Lo YR; Ishikawa N; Wi T; Lahra MM
    PLoS One; 2019; 14(4):e0213312. PubMed ID: 30943199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
    BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
    Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
    BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
    Jacobsson S; Cole MJ; Spiteri G; Day M; Unemo M;
    BMC Infect Dis; 2021 Mar; 21(1):273. PubMed ID: 33736608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
    Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
    BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.
    Kubanova A; Kubanov A; Frigo N; Solomka V; Semina V; Vorobyev D; Khairullin R; Unemo M
    BMC Infect Dis; 2014 Jun; 14():342. PubMed ID: 24947981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
    Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
    Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
    Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M;
    BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study.
    Unemo M; Lahra MM; Escher M; Eremin S; Cole MJ; Galarza P; Ndowa F; Martin I; Dillon JR; Galas M; Ramon-Pardo P; Weinstock H; Wi T
    Lancet Microbe; 2021 Nov; 2(11):e627-e636. PubMed ID: 35544082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017-2019.
    Adamson PC; Van Le H; Le HHL; Le GM; Nguyen TV; Klausner JD
    BMC Infect Dis; 2020 Nov; 20(1):809. PubMed ID: 33153450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016.
    Yin YP; Han Y; Dai XQ; Zheng HP; Chen SC; Zhu BY; Yong G; Zhong N; Hu LH; Cao WL; Zheng ZJ; Wang F; Zhi Q; Zhu XY; Chen XS
    PLoS Med; 2018 Feb; 15(2):e1002499. PubMed ID: 29408881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissemination and genome analysis of high-level ceftriaxone-resistant
    Lin X; Chen W; Xie Q; Yu Y; Liao Y; Feng Z; Qin X; Wu X; Tang S; Zheng H
    Emerg Microbes Infect; 2022 Dec; 11(1):344-350. PubMed ID: 34994305
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis.
    Bala M; Kakran M; Singh V; Sood S; Ramesh V;
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv28-35. PubMed ID: 24243876
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X
    Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998.
    Sosa J; Ramirez-Arcos S; Ruben M; Li H; Llanes R; Llop A; Dillon JA
    Sex Transm Dis; 2003 May; 30(5):443-8. PubMed ID: 12916137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility testing and molecular characterization of
    Zolfaghari P; Emamie AD; Rajabpour M; Zarei A; Whiley DM; Pourmand MR; Pourmand G
    Int J STD AIDS; 2022 Jun; 33(7):660-665. PubMed ID: 35485393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea.
    Unemo M; Golparian D; Eyre DW
    Methods Mol Biol; 2019; 1997():37-58. PubMed ID: 31119616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic and behavioural factors associated with antimicrobial susceptibility to azithromycin and ceftriaxone in
    Forster RF; Smith M; Cooper G; Brokenshire M; Roberts SA; McAuliffe GN
    Int J STD AIDS; 2021 Jan; 32(1):67-74. PubMed ID: 33198606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.